Schrodinger Inc at Bank of America Tech Solutions for Drug Discovery Conference (Virtual) Transcript
Great. And we're going to kick off our next session. Thank you for joining us, everyone. My name is Mike Ryskin, Bank of America life science tools and diagnostics analyst. Joining me from the team is the senior analyst, Derik De Bruin. And for our next session, we have Schrödinger with us. Joining us is Joel Lebowitz, CFO; Karen Akinsanya, Chief Biomedical scientists. And we also have Dr. Robert Abel, Chief Computational scientists.
And to kick it off, I think we're going to have a brief company presentation just to go over some background and to sort of set the table a little bit. And then we'll go into the fireside chat Q&A format that we've done before.
So with that, Robert, take it away.
¶ -
Thank you so much, Mike. Delighted to share about Schrödinger. So on Slide 2, you'll see typical cautionary notes.
On Slide
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
